ClinicalTrials.Veeva

Menu

The Association of Gut Microbiota With COVID 19 Infection in Children

H

Hallym University Kangnam Sacred Heart Hospital

Status

Enrolling

Conditions

Gut Microbiome
Childhood ALL
Coronavirus Infections

Treatments

Diagnostic Test: 16S rRNA sequencing

Study type

Observational

Funder types

Other

Identifiers

NCT05303155
Covid 19 and Gut Microbiota

Details and patient eligibility

About

Although COVID-19 infects gastrointestinal tissues, little is known about the roles of gut commensal microbes in susceptibility to and severity of infection. The investigators will analyze the alterations in fecal microbiomes of patients with COVID-19 infection during hospitalization.

Enrollment

40 estimated patients

Sex

All

Ages

3 months to 15 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients infected with COVID 19

Exclusion criteria

  • congenital heart, renal, intestinal disease
  • malignancy
  • immunologic disease

Trial design

40 participants in 2 patient groups

Patient with COVID 19
Description:
Pediatric patient infected by COVID 19
Treatment:
Diagnostic Test: 16S rRNA sequencing
Pediatric patient without infection of COVID 19
Description:
Pediatric patient without infection of COVID 19
Treatment:
Diagnostic Test: 16S rRNA sequencing

Trial contacts and locations

1

Loading...

Central trial contact

KY YOUNG CHO, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems